First Generic Epipen ApprovedAschenbrenner, Diane S. MS, RNAJN The American Journal of Nursing: December 2018 - Volume 118 - Issue 12 - p 23–24 doi: 10.1097/01.NAJ.0000549688.51382.a8 Drug Watch Buy Abstract Author InformationAuthors Article MetricsMetrics The Food and Drug Administration has granted Teva Pharmaceuticals approval to market the first generic version of the EpiPen. Some of the controversies surrounding approval of this generic product are described below. Alternatives to the EpiPen are also highlighted. Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch: email@example.com. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.